Encision Inc. Share Price

ECIA

US29254Q1040

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets 19:22:31 01/09/2026 BST			5-day change	1st Jan Change
0.0406 ^USD	-78.62%		0.00%	-71.00%

12-12	Encision Inc. Announces Management Changes	CI
12-12	Encision Inc. Announces CEO Changes	CI

Encision Inc. is a medical device company. It designs, develops, manufactures and markets patented surgical instruments that provide safety to patients undergoing minimally invasive surgery. Its segments include Product and Service. The Product segment designs, develops, manufactures and markets patented surgical instruments. The Service segment performs electrical engineering activities for external entities. Its Active Electrode Monitoring (AEM) technology provides surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures, while preventing stray electrosurgical energy that can cause tissue injury that may result in death. The AEM system consists of shielded 5mm AEM Instruments and an AEM monitor. Laparoscopic instruments have the integrated AEM design and include the full range of instruments that are common in laparoscopic surgery. The AEM monitor is compatible with electrosurgical generators.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Stock Market
Stocks
ECIA Stock

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!

SEIZE THE OFFER!

Market Cap	2.19M 1.89M 1.79M 1.62M 3.04M 210M 3.06M 21.26M 8.18M 107M 8.24M 8.06M 337M	P/E 2024	-12.5x	P/E 2025	-23.9x
Enterprise Value	3.25M 2.8M 2.65M 2.4M 4.51M 311M 4.53M 31.5M 12.11M 158M 12.21M 11.94M 499M	EV / Sales 2024	1.54x	EV / Sales 2025	1.03x
Free-Float	38.58%	Yield 2024 *	-	Yield 2025	-

12-12	Encision Inc. Announces Management Changes	CI
12-12	Encision Inc. Announces CEO Changes	CI
11-13	Encision Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
11-03	Encision Inc. Announces Resignation of Patrick Pace from Its Board of Directors, Effective October 30, 2025	CI
18/08/25	Encision Inc. announced that it has received $0.5 million in funding	CI
15/08/25	Encision Inc. Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
10/07/25	Encision Inc. Reports Earnings Results for the Full Year Ended March 31, 2025	CI
14/02/25	Encision Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	CI
15/11/24	Earnings Flash (ECIA) ENCISION Reports Fiscal Q2 Revenue $1.8M	MT
14/11/24	Encision Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024	CI
14/08/24	Encision Inc. Reports Earnings Results for the First Quarter Ended June 30, 2024	CI
15/07/24	Earnings Flash (ECIA) ENCISION Reports Q4 Revenue $1.5M	MT
15/07/24	Encision Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI

09-11	Encision Completes $80,000 Private Placement	AQ
07-16	Encision : Announces Start of Stock Trading	PU
07-14	Encision Inc. Announces Start of Stock Trading	AQ
05-04	Encision Inc. Announces Halt of Stock Trading	AQ
04-13	Encision Inc. Announces Fiscal 2026 Fourth Quarter and Full Year Results	AQ

1 day	-78.62%
Current month	-78.62%
1 month	-4.92%
3 months	+13,433.33%
6 months	-72.92%
Current year	-71.00%

1 month	0.04	0.19
Current year	0	0.2
1 year	0	0.39
3 years	0	0.75
5 years	0	1.5
10 years	0	1.5

Encision Inc. Share Price

Stocks

ECIA

US29254Q1040

Medical Equipment, Supplies & Distribution

Valuation : Encision Inc.

Chart: Encision Inc.

Latest news : Encision Inc.

Press Releases : Encision Inc.

Quotes and Performance

Price Extremes

Managers and Directors : Encision Inc.

Latest insider transactions

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Manager	Title	Age	Since
Robert Fries CEO	Chief Executive Officer	77	07/12/2025
Brandon Shepard DFI	Director of Finance/CFO	42	31/07/2024
Denise Baker LAW	General Counsel	-	31/12/2018

Director	Title	Age	Since
Vern Kornelsen BRD	Director/Board Member	93	31/12/1990
Robert Fries BRD	Director/Board Member	77	16/04/2024

Date	Insider	Type	Main position	Quantity	% Market Cap.
15/04/26	Robert Fries	Buy	Chief Executive Officer	166,785	0.9881%
18/11/25	Gregory Trudel	Free	Chief Executive Officer	10,000	0.0592%
18/11/25	Brian Jackman	Free	VP of Marketing	10,000	0.0592%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ENCISION INC.	-78.62%	0.00%	-89.37%	-90.94%	685K
ABBOTT LABORATORIES	-1.36%	-5.89%	-23.14%	-0.49%	176B
MEDTRONIC PLC	-0.72%	-3.41%	-3.49%	+11.74%	116B
CENCORA, INC.	+0.19%	-2.83%	+6.20%	+80.93%	61.36B
HOYA CORPORATION	-1.92%	-6.01%	+8.80%	+41.11%	49.42B
BECTON, DICKINSON AND COMPANY	+0.81%	-3.73%	-6.67%	-33.43%	48.44B
DEXCOM, INC.	-1.75%	-5.54%	+9.25%	-22.61%	31.33B
MEDLINE INC.	+0.43%	-11.10%	-	-	28.56B
WEST PHARMACEUTICAL SERVICES, INC.	+0.58%	+1.84%	+31.28%	-12.82%	24.37B
TERUMO CORPORATION	+0.49%	-7.65%	-12.44%	+4.86%	21.57B
Average	-8.19%	-4.57%	-8.84%	-2.41%	55.78B
Weighted average by Cap.	-0.69%	-4.90%	-6.07%	+10.85%

	2024	2025
Net sales	6.59M 5.67M 5.37M 4.87M 9.14M 629M 9.18M 63.81M 24.54M 320M 24.73M 24.19M 1.01B	6.56M 5.65M 5.35M 4.85M 9.09M 626M 9.14M 63.52M 24.43M 319M 24.62M 24.08M 1.01B
Net income	-692K -596K -564K -512K -960K -66.09M -965K -6.7M -2.58M -33.62M -2.6M -2.54M -106M	-220K -190K -180K -163K -305K -21.04M -307K -2.13M -820K -10.7M -827K -809K -33.82M
Net Debt	1.29M 1.11M 1.05M 954K 1.79M 123M 1.8M 12.51M 4.81M 62.73M 4.85M 4.74M 198M	1.06M 910K 862K 781K 1.47M 101M 1.47M 10.24M 3.94M 51.36M 3.97M 3.88M 162M